Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Century Therapeutics (IPSC) Non-Current Debt (2022)

Historic Non-Current Debt for Century Therapeutics (IPSC) over the last 1 years, with Q4 2022 value amounting to $3.7 million.

  • Century Therapeutics' Non-Current Debt changed N/A to $3.7 million in Q4 2022 from the same period last year, while for Dec 2022 it was $3.7 million, marking a year-over-year change of. This contributed to the annual value of $3.7 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Century Therapeutics reported Non-Current Debt of $3.7 million as of Q4 2022.
  • In the past 5 years, Century Therapeutics' Non-Current Debt ranged from a high of $10.0 million in Q1 2022 and a low of $3.7 million during Q4 2022